Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NewMed Energy LPDKDRF +9.04%71 ROE % is 0.02% as of Mar. 2026, which is 100% below its 10-year median of 38.96. GuruFocus rates DKDRF with a GF Score™ of 71/100 and a GF Value™ of $2.87 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 955 Oil & Gas companies, NewMed Energy LP ranks better than 69.11% on this metric.
The historical rank and industry rank for NewMed Energy LP's ROE % or its related term are showing as below:
DKDRF'
s ROE % Range Over the Past 10 Years
Min: 12.12 Med: 38.96 Max: 116.13
Current: 12.12
During the past 13 years, NewMed Energy LP's highest ROE % was 116.13%. The lowest was 12.12%. And the median was 38.96%.
DKDRF's ROE % is ranked better than 69.11% of 955
companies
in the Oil & Gas industry
Industry Median: 5.89
vs DKDRF: 12.12
NewMed Energy LP (OTCPK:DKDRF) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
NewMed Energy LP ROE % Related Terms
NewMed Energy LP ROE % Historical Data
* Premium members only.
The historical data trend for NewMed Energy LP's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Oil & Gas E&P subindustry, NewMed Energy LP's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewMed Energy LP ROE % vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, NewMed Energy LP's ROE % distribution charts can be found below:
* The bar in red indicates where NewMed Energy LP's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
NewMed Energy LP (DKDRF) has a ROE % of 0.02% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on NewMed Energy LP and its competitors. This is 100% below median its historical median of 38.96. Over the past decade, NewMed Energy LP's ROE % has ranged from 12.12 to 116.13. According to the industry distribution chart, NewMed Energy LP ranks #295 out of 955 companies in the Oil & Gas industry, placing it in the top 30.9%.
Is NewMed Energy LP's ROE % too high?
NewMed Energy LP's current ROE % of 0.02% is 100% below median its 10-year median of 38.96. Over the past 10 years, this metric has ranged from a low of 12.12 to a high of 116.13. The Oil & Gas industry median ROE % is 5.89. NewMed Energy LP's value of 0.02% is 99.7% below this industry median. Based on the distribution chart, NewMed Energy LP ranks #295 out of 955 companies in the Oil & Gas industry, which is above the industry midpoint. Overall, NewMed Energy LP has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NewMed Energy LP's ROE % compare to COP and EOG?
According to the Oil & Gas industry distribution chart, NewMed Energy LP ranks #295 out of 955 companies for ROE %. This puts NewMed Energy LP in the upper half of its industry. The industry median ROE % is 5.89. NewMed Energy LP's value of 0.02% is 99.7% below this benchmark. Historically, NewMed Energy LP's own ROE % has ranged from 12.12 to 116.13 over the past decade. While the company's 10-year median is 38.96 vs. the industry median of 5.89, NewMed Energy LP has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Oil & Gas company?
The median ROE % among Oil & Gas companies is 5.89, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NewMed Energy LP's current ROE % of 0.02% is 99.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on NewMed Energy LP and its competitors. For the Oil & Gas industry, the median ROE % is 5.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewMed Energy LP's current ROE % is 0.02%, which is 100% below median its own 10-year median of 38.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewMed Energy LP stock overvalued right now?
Based on GuruFocus' analysis, NewMed Energy LP (DKDRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.87, compared to a current price of $5.58 — trading 94.4% above its estimated fair value. The current ROE % is 0.02%, which is 100% below median its 10-year median of 38.96 and 99.7% below the Oil & Gas industry median of 5.89. NewMed Energy LP's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For NewMed Energy LP (DKDRF), the current ROE % is 0.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NewMed Energy LP (DKDRF) Overvalued in 2026?
Based on GuruFocus' analysis, NewMed Energy LP stock appears to be overvalued.
The current stock price of $5.58 is trading 94.4% above its estimated GF Value™ of $2.87.
GuruFocus considers NewMed Energy LP to be Significantly Overvalued.
Key valuation signals for DKDRF:
ROE %: 0.02% (100% below median its 10-year median of 38.96)
GF Value™: $2.87 vs. price of $5.58 (94.4% above fair value)
Industry Position: 99.7% below the Oil & Gas median (#295 of 955)
No single metric tells the full story. See the DKDRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NewMed Energy LP operates in the energy field. Its primary business is exploring, developing, producing, and marketing natural gas, condensate, and oil in Israel and Cyprus and promoting various natural gas-based projects. The Partnership aims to increase the volume of its natural gas sales.
71GF Score
Get the complete analysis for DKDRF
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DKDRF has been successfully added to your 
